ES2036039T3 - Procedimiento de preparacion de una composicion a base de fases laminares lipidicas hidratadas o de liposomas. - Google Patents

Procedimiento de preparacion de una composicion a base de fases laminares lipidicas hidratadas o de liposomas.

Info

Publication number
ES2036039T3
ES2036039T3 ES198989400177T ES89400177T ES2036039T3 ES 2036039 T3 ES2036039 T3 ES 2036039T3 ES 198989400177 T ES198989400177 T ES 198989400177T ES 89400177 T ES89400177 T ES 89400177T ES 2036039 T3 ES2036039 T3 ES 2036039T3
Authority
ES
Spain
Prior art keywords
baicaleine
liposomes
lip
phases
composition based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198989400177T
Other languages
English (en)
Inventor
Alain Meybeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LVMH Recherche GIE
Original Assignee
LVMH Recherche GIE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9364112&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2036039(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LVMH Recherche GIE filed Critical LVMH Recherche GIE
Application granted granted Critical
Publication of ES2036039T3 publication Critical patent/ES2036039T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Nanotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Neurosurgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)

Abstract

EL INVENTO ES UNA COMPOSICION A BASE DE FASES LAMINARES LIPIDICAS HIDRATADAS O DE LIPOSOMAS. ESTA COMPOSICION SE CARACTERIZA POR CONTENER AL MENOS EN PARTE UN EXTRACTO DE SCUTELLARIA, O AL MENOS UNA SUBSTANCIA ACTIVA AISLADA DE TAL EXTRACTO U OBTENIDA POR SINTESIS QUIMICA, ESPECIALMENTE WOGONINA, 2''- HIDROXI -WOGONINA, BAICALEINA, NEOBAICOLEINA, OROXIDINA Y BAICALINA. ESTA COMPOSICION ES UTIL PARA PREPARAR COMPOSICIONES COSMETICAS O FARMACEUTICAS, ESPECIALMENTE DERMATOLOGICAS, CON ACTIVIDAD ANTI- ALERGICA, ANTI- INFLAMATORIA O ANTIENVEJECIMIENTO.
ES198989400177T 1988-03-09 1989-01-23 Procedimiento de preparacion de una composicion a base de fases laminares lipidicas hidratadas o de liposomas. Expired - Lifetime ES2036039T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8803066A FR2628317B1 (fr) 1988-03-09 1988-03-09 Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de scutellaria, ou au moins un flavonoide tel que baicaleine ou baicaline et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite anti-allergique, anti-inflammatoire ou anti-vieillissement, l'incorporant

Publications (1)

Publication Number Publication Date
ES2036039T3 true ES2036039T3 (es) 1993-05-01

Family

ID=9364112

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198989400177T Expired - Lifetime ES2036039T3 (es) 1988-03-09 1989-01-23 Procedimiento de preparacion de una composicion a base de fases laminares lipidicas hidratadas o de liposomas.

Country Status (9)

Country Link
US (2) US5443839A (es)
EP (1) EP0332478B1 (es)
JP (1) JP2935518B2 (es)
CN (1) CN1033365C (es)
AT (1) ATE73992T1 (es)
DE (2) DE68901053D1 (es)
ES (1) ES2036039T3 (es)
FR (1) FR2628317B1 (es)
WO (1) WO1989008447A1 (es)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2753719B2 (ja) * 1988-12-15 1998-05-20 日本油脂株式会社 リポソーム製剤の製造法
FR2657526B1 (fr) * 1990-01-31 1994-10-28 Lvmh Rech Utilisation d'un phosphate d'alpha-tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, dermatologiques, ou pharmaceutiques; compositions ainsi obtenues.
ES2071081T3 (es) * 1990-06-11 1995-06-16 Idi Farmaceutici Spa Liposomas fosfolipidicos que contienen principios activos y un procedimiento para su obtencion.
CH683594A5 (de) * 1991-01-24 1994-04-15 Flachsmann Ag Emil Verfahren zur Herstellung eines Pflanzenextrakt enthaltenden Masse, welche insbesondere für die Einkapselung in ein festes Umhüllungsmaterial geeignet ist.
US5643597A (en) * 1991-08-01 1997-07-01 Lvmh Recherche Use of a tocopherol phosphate or one of its derivatives for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained
FR2679904A1 (fr) * 1991-08-01 1993-02-05 Lvmh Rech Utilisation d'un phosphate de tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, ou pharmaceutiques et compositions ainsi obtenues.
CA2159626C (en) * 1993-04-02 2001-10-02 Lingna Li Method for delivering beneficial compositions to hair follicles
US7556825B2 (en) * 1993-04-02 2009-07-07 Anticancer, Inc. Method for promoting hair growth
FR2736829B1 (fr) * 1995-07-20 1997-09-12 Oreal Composition pour lutter contre les taches et/ou le vieillissement de la peau, ses utilisations
US6071535A (en) * 1996-01-31 2000-06-06 Collaborative Laboratories, Inc. Lipid vesicles formed with alkylammonium fatty acid salts
US6183774B1 (en) 1996-01-31 2001-02-06 Collaborative Laboratories, Inc. Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts
US5874105A (en) * 1996-01-31 1999-02-23 Collaborative Laboratories, Inc. Lipid vesicles formed with alkylammonium fatty acid salts
US6013278A (en) * 1996-05-14 2000-01-11 Burzynski Research Institute Liposomal antineoplaston therapies with markedly improved antineoplastic activity
FR2754713B1 (fr) * 1996-10-22 1999-01-08 Roc Sa Utilisation de complexes pour la preparation de compositions pour le traitement des peaux sensibles, procede de preparation et compositions hypoallergeniques
US5935572A (en) * 1997-01-10 1999-08-10 Collaborative Laboratories, Inc. Composition containing protease separate from glycosidase for removing nits in treating lice infestation
US20040101576A1 (en) * 1997-03-21 2004-05-27 Eiichiro Yagi Immunopotentiators
PL187310B1 (pl) * 1997-04-29 2004-06-30 Antoni Gwardys Naturalny preparat przeciwutleniający
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
AU2904899A (en) * 1998-03-16 1999-10-11 Procter & Gamble Company, The Compositions for regulating skin appearance
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US6084080A (en) * 1999-01-15 2000-07-04 Farlong International Inc. Breviscapinum and extracting process thereof from erigeron breviscapus
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US6184246B1 (en) * 1999-07-30 2001-02-06 The United States Of America As Represented By The Secretary Of Agriculture Inhibition of cytokine production by polymethoxylated flavones
US7309688B2 (en) * 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
US6290995B1 (en) * 2000-02-08 2001-09-18 Zhao Xinxian Plant drug for preventing cancer II
EP1127572A3 (en) * 2000-02-25 2003-05-02 Basf Aktiengesellschaft Use of flavones for treating cycloxygenase-2 mediated diseases
CN1309399C (zh) 2000-10-25 2007-04-11 国家中药制药工程技术研究中心 复方双黄连制剂及制备方法
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US6555143B2 (en) 2001-02-28 2003-04-29 Johnson & Johnson Consumer Products, Inc. Legume products
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
KR100434898B1 (ko) * 2001-06-26 2004-06-07 나드리화장품주식회사 액정좀으로 안정화된 약용 식물 복합 추출액 함유 화장료조성물
KR100444196B1 (ko) * 2001-06-26 2004-08-11 나드리화장품주식회사 나노리포좀으로 안정화된 약용식물 복합 추출액 함유화장료 조성물
DE10139793A1 (de) * 2001-08-14 2003-02-27 Beiersdorf Ag Verwendung von Wogonin zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Prophylaxe und Behandlung von entzündlichen Hautzuständen und/oder zum Hautschutz bei empfindlich determinierter und trockener Haut
DE10139791A1 (de) * 2001-08-14 2003-02-27 Beiersdorf Ag Verwendung von Oroxylin A zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Prophylaxe und Behandlung von entzündlichen Hautzuständen und/oder zum Hautschutz bei empfindlich determinierter und trockener Haut
US7258877B2 (en) * 2001-12-21 2007-08-21 Sunten Phytotech Co., Ltd. Herbal pharmaceutical composition for treatment of cardiovascular disease
TWI275397B (en) 2001-12-21 2007-03-11 Sun Ten Pharmaceutical Co Ltd Herbal composition, use thereof in protection of endothelial cell and in anti-inflammation, and preparation method thereof
US7108868B2 (en) 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US7972632B2 (en) 2003-02-28 2011-07-05 Unigen Pharmaceuticals, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
US20030165588A1 (en) 2002-03-01 2003-09-04 Unigen Pharmaceuticals, Inc. Identification of free-B-ring flavonoids as potent COX-2 inhibitors
US20050032882A1 (en) * 2002-03-06 2005-02-10 Sophie Chen Botanical extract compositions and methods of use
US8034387B2 (en) * 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
EP2108370A1 (en) * 2002-04-30 2009-10-14 Unigen Pharmaceuticals, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
US8945518B2 (en) * 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
KR100512330B1 (ko) * 2002-08-13 2005-09-02 나드리화장품주식회사 나노리포좀으로 안정화된 바오밥나무 추출물을 함유하는피부 보습 화장료 조성물
KR101156970B1 (ko) * 2002-12-03 2012-06-20 포라 가세이 고교 가부시키가이샤 멜라노사이트의 수상돌기 신장 억제제 및 이를 함유하는피부 외용제
US8709038B2 (en) * 2002-12-20 2014-04-29 Boston Scientific Scimed, Inc. Puncture hole sealing device
US20040220119A1 (en) * 2003-04-04 2004-11-04 Unigen Pharmaceuticals, Inc. Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care
NZ545565A (en) * 2003-09-02 2009-06-26 Unigen Pharmaceuticals Inc Formulation of a mixture of Free-B-Ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US7405195B2 (en) * 2006-03-27 2008-07-29 Natural Beauty Bio-Technology Limited Cosmetic compositions
CN101088523B (zh) * 2006-06-12 2012-08-22 北京五和博澳医药科技发展有限公司 黄芩天然活性成分的固体脂质纳米粒及其制备方法和制剂
KR100761248B1 (ko) 2006-10-12 2007-10-04 주식회사 유니젠 대나무 및 황금 추출물을 유효성분으로 함유하는 아토피성피부염 치료를 위한 조성물
EP1932517A3 (en) * 2006-12-11 2008-07-16 Universiteit Utrecht Holding B.V. Liposomes containing a polyphenol derivative such as caffeic acid and a method of post-loading thereof
CH715456B1 (de) 2007-04-27 2020-04-30 Mibelle Ag Kosmetisches Produkt zur topischen Anwendung für den Schutz und die Erneuerung von Hautstammzellen, welches sich von dedifferenzierten Pflanzenzellen ableitet.
KR100982435B1 (ko) * 2008-02-25 2010-09-15 인하대학교 산학협력단 （２ｚ，８ｚ）―매트리카리아산 메틸 에스테르를유효성분으로 함유하는 피부 미백용 조성물
CN102258460B (zh) * 2010-09-21 2012-11-21 河南科技大学 黄芩素脂质体凝胶及其制备方法
JP2012176923A (ja) * 2011-02-28 2012-09-13 Kose Corp 抗酸化剤、ハリ・タルミ改善剤、ラジカル消去剤、エラスターゼ活性阻害剤、並びに抗老化剤
KR101830864B1 (ko) * 2011-10-05 2018-02-22 (주)아모레퍼시픽 탈모방지 또는 모발 성장 촉진용 화장료 조성물
CN102389150B (zh) * 2011-10-09 2014-04-16 中国计量学院 包封儿茶素的脂质体的制备方法
CN108883069B (zh) * 2016-01-04 2021-07-20 中央研究院 基于酯化/皂化的用于微脂体负载的方法
CN108532989B (zh) * 2018-04-02 2019-12-03 上海理工大学 便携式升降换衣间
CN111166739B (zh) * 2020-02-18 2021-04-20 西安交通大学 柯因在制备抗类过敏药物中的应用
CN118376721B (zh) * 2024-04-24 2025-09-02 四川新绿色药业科技发展有限公司 一种黄芩配方颗粒、黄芩炭配方颗粒的薄层鉴别方法
CN118121985B (zh) * 2024-05-08 2024-08-06 北京安德普泰医疗科技有限公司 一种提取植物黄酮的方法及含黄酮滤液的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
JPS55127309A (en) * 1979-03-23 1980-10-02 Kishiyouhin Kagaku Kaihou Kenkyusho:Kk Cosmetic
DE3365744D1 (en) * 1982-01-22 1986-10-09 Fisons Plc Liposome and sodium cromoglycate compositions, and methods for their preparation
US4670185A (en) * 1982-07-19 1987-06-02 Lion Corporation Aqueous vesicle dispersion having surface charge
CA1237671A (en) * 1983-08-01 1988-06-07 Michael W. Fountain Enhancement of pharmaceutical activity
JPS6150918A (ja) * 1984-08-20 1986-03-13 Ichimaru Fuarukosu Kk バイカリン又はバイカレイン含有化粧料用組成液
SE462894B (sv) * 1985-10-28 1990-09-17 Biogram Ab Mikrokapslar, foerfarande foer framstaellning daerav samt anvaendning
DE3542773A1 (de) * 1985-12-04 1987-06-11 Roehm Pharma Gmbh Hautwirksame pharmaka mit liposomen als wirkstofftraeger
EP0278809B1 (fr) * 1987-01-19 1992-03-25 Parfums Rochas Nouvelles compositions cosmétiques ou dermatologiques renfermant un extrait des fruits de Silybum Marianum riche en Silymarine associé à des acides gras essentiels
US4917951A (en) * 1987-07-28 1990-04-17 Micro-Pak, Inc. Lipid vesicles formed of surfactants and steroids
US4828837A (en) * 1987-03-30 1989-05-09 Liposome Technology, Inc. Non-crystalline minoxidil composition, its production and application

Also Published As

Publication number Publication date
WO1989008447A1 (fr) 1989-09-21
EP0332478A1 (fr) 1989-09-13
US5643598A (en) 1997-07-01
CN1037834A (zh) 1989-12-13
ATE73992T1 (de) 1992-04-15
FR2628317A1 (fr) 1989-09-15
FR2628317B1 (fr) 1991-11-08
CN1033365C (zh) 1996-11-27
US5443839A (en) 1995-08-22
JPH03504598A (ja) 1991-10-09
DE68901053D1 (de) 1992-04-30
JP2935518B2 (ja) 1999-08-16
DE332478T1 (de) 1990-02-08
EP0332478B1 (fr) 1992-03-25

Similar Documents

Publication Publication Date Title
ES2036039T3 (es) Procedimiento de preparacion de una composicion a base de fases laminares lipidicas hidratadas o de liposomas.
ES2052755T3 (es) Procedimiento de preparacion de una composicion a base de fases laminares lipidicas hidratadas o de liposomas.
BR9714064A (pt) Composição farmacêutica
MX9305798A (es) Composiciones de lapiz labial humedecedor.
FR2669225B1 (fr) Utilisation de saponines de medicago pour la preparation de compositions cosmetiques ou pharmaceutiques, notamment dermatologiques.
AU585495B2 (en) Pharmaceutical composition for the treatment of acute myocardial ischemia
FR2627385B3 (fr) Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
ES8702143A1 (es) Un procedimiento para preparar derivados de piperazina con actividad psicotropica
FR2784294B1 (fr) Composition cosmetique et/ou dermatologique renfermant au moins un extrait de murier, au moins un extrait de scutellaire et au moins un derive d'acide salicylique
MY101784A (en) Novel pharmacological compounds
FR2650953B1 (fr) Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant au moins un derive de labdane, ou un extrait de plante en contenant; composition cosmetique ou pharmaceutique, notamment dermatologique l'incorporant
IT1284971B1 (it) Formulazioni farmaceutiche e cosmetiche ad attivita' antiacne
FR2609395B1 (fr) Utilisation de bases xanthiques comme principe actif d'une composition pharmaceutique, notamment dermatologique, ou cosmetique, composition notamment utile comme matiere de base pour la preparation de composition pharmaceutique ou cosmetique et composition pharmaceutique ou cosmetique ainsi preparee
IT1299583B1 (it) Uso di proteine hmg-i per la preparazione di medicamenti ad attivita' citotossica
MY120683A (en) New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals.
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
TR199900662T2 (xx) 1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m�
FR2701847B1 (fr) Compositions pharmaceutiques et cosmétiques à base d'albumine végétale, préparations contenant de telles compositions et procédé de préparation.
AU3080795A (en) Novel combination product comprising an antifungal agent and crotamiton as an antifungal activity enhancer and dermatological or cosmetic compositions comprising same
ATE241975T1 (de) Arzneimittel enthaltend platinkomplexverbindungen sowie deren verwendung
EP0348215A3 (en) Novel cosmetic and paramedicinal compositions
IT1186754B (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo diidrossi-1,8 fenil-10 antrone-9,e procedimento di preparazione dell'ingrediente attivo
GB1359969A (en) Skin protective compositions
TW375526B (en) Cosmetic ingredient composition

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 332478

Country of ref document: ES